The startup bug has hit the world of biotechnology, and the latest victim is a business that is building a “super glue” — coincidentally, for bug-combatting vaccines. SpyBiotech — a startup spun out of Oxford University that has developed way to bond antigens to viruses and other particles to make vaccines — has announced £4 million ($5 million) in funding… Read More...